$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

황련추출물-ceramide 복합물의 지방장벽 형성 조절을 통한 상피 염증 완화 효과
Effect of Epithelial Inflammation Relief through Regulation of Lipid Barrier Formation of Coptidis Rhizoma Extract-Ceramide Complex 원문보기

大韓韓方小兒科學會誌 = The journal of pediatrics of Korean medicine, v.35 no.3, 2021년, pp.128 - 137  

안상현 (세명대학교 한의과대학 해부학교실) ,  김기봉 (부산대학교 한의학전문대학원)

Abstract AI-Helper 아이콘AI-Helper

Objective The purpose of this study was to confirm the effectiveness of coptidis rhizoma extract-ceramide complex on skin barrier, transepidermal water loss (TEWL) and pH reduction, and inflammation of the skin. Methods Coptidis rhizoma extract-ceramide complex was applied in 6-week-old Balb/C mice ...

주제어

표/그림 (3)

참고문헌 (53)

  1. Kim YJ, Ahn JY, Seo SJ, Hong CK. The effect of retinoic acid on expression of human beta defensin-2 and LL-37 in keratinocyte. J Korean Invest Dermatol. 2007;14:29-35. 

  2. Kwon MS, Choi TB, Kim GY. The effect on the skin barrier function of ceramide. Kor J Aesthet Cosmetol. 2005;3(1):131-7. 

  3. Yoon YM, Yoon JY, Lim KM, Hahn HJ, Kim YR, Ahn KJ, An SK. Effects of the complex containing Centella asiatica-and folic acid-fermented extracts, acetyl glutamine, and nicotinic acid adenine dinucleotide phosphate on the inhibition of senescence and elanogenesis, promotion of collagen expression, cellular regeneration, and keratinocyte differentiation, and anti-inflammation. Kor J Aesthet Cosmetol. 2013;11(4):675-84. 

  4. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 1995;270(30):17702-11. 

  5. Steven AC, Steinert PM. Protein composition of cornified cell envelopes of epidermal keratinocytes. J Cell Sci. 1994;107(2):693-700. 

  6. Elias PM, Menon GK. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res. 1991;24:1-26. 

  7. Steinert PM, Cantieri JS, Teller DC, Lonsdale-Eccles JD, Dale BA. Characterization of a class of cationic proteins that specifically interact with intermediate filaments. Proc Natl Acad Sci USA. 1981;78(7):4097-101. 

  8. Cornelissen C, Marquardt Y, Czaja K, Wenzel J, Frank J, Luscher-Firzlaff J, Luscher B, Baron J. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129(2):426-33. 

  9. Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol. 2006;126(6):1200-2. 

  10. Palmer CN, Irvine AD, Terron-Kwiatkowski A, Zhao Y, Liao H, Lee SP, Goudie DR, Sandilands A, Campbell LE, Smith FJ, O'Regan GM, Watson RM, Cecil JE, Bale SJ, Compton JG, DiGiovanna JJ, Fleckman P, Lewis-Jones S, Arseculeratne G, Sergeant A, Munro CS, Houate BE, McElreavey K, Halkjaer LB, Bisgaard H, Mukhopadhyay S, McLean WH. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet. 2006;38(4):441-6. 

  11. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40:965-72. 

  12. Barnes KC. An update on the genetics of atopic dermatitis: scratching the surface in 2009. J Allergy Clin Immunol. 2010;125(1):16-29. 

  13. Kim BB, Kim JR, Kim JH, Kim YA, Park JS, Yeom MH, Lee HJ, Lee KW, Kang NJ. 7,3',4'-Trihydroxyisoflavone ameliorates the development of Dermatophagoides farinae-induced atopic dermatitis in NC/Nga Mice. Evid-Based Complement Alternat Med. 2013;2013:636597 

  14. Weidinger S, Novak N. Atopic dermatitis. Lancet (London, England). 2016;387(10023):1109-22. 

  15. Kim JH. Current understanding of atopic dermatitis. Pediatr Allergy Respir Dis. 2004;14(1):12-23. 

  16. Boguniewicz M. Atopic dermatitis: the updated practice parameter and beyond. Allergy Asthma Proc. 2014;35(6):429-34. 

  17. Kim BE, Leung D. Epidermal barrier in atopic dermatitis. Immunol Res. 2012;4(1):12-6. 

  18. Hogan MB, Peele K, Wilson NW. Skin barrier function and its importance at the start of the atopic march. J Allergy (Cairo). 2012;2012:901940. 

  19. Boguniewicz M, Eichenfield LF, Hultsch T. Current management of atopic dermatitis and interruption of the atopic march. J Allergy Clin Immunol. 2003;112(6):140-50. 

  20. Im GM, Kim HJ, Jeong WY, Jeong HW. Oriental medical approach on the allergic disease. Korea J Oriental Physiology & Pathology. 2002;16(5):831-9. 

  21. Cha HY, Ahn SH, Cheon JH, Park SY, Kim KB. Hataedock treatment has preventive therapeutic effects for atopic dermatitis through skin barrier protection in Dermatophagoides farinae-induced NC/Nga mice. J Ethnopharmacol. 2017;206:327-36. 

  22. Muluye RA, Bian Y, Alemu PN. Anti-inflammatory and antimicrobial effects of heat-clearing Chinese herbs: a current review. J Tradit Complement Med. 2014;4(2):93-8. 

  23. Tang J, Feng YB, Tsao S, Wang N, Curtain R, Wang YW. Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. J Ethnopharmacol 2009;126(1):5-17. 

  24. Chin LW, Cheng YW, Lin SS, Lai YY, Lin LY, Chou MY, Chou MC, Yang CC. Anti-herpes simplex virus effects of berberine from Coptidis Rhizoma, a major component of a Chinese herbal medicine, Ching-Wei-San. Arch Virol 2010;155(12):1933-41. 

  25. Yu YE, Park EY, Jung DH, Byun SH, Kim SC, Park SM. Antibacterial activity of oriental medicinal herb extracts against skin pathogens. J Life Sci. 2010;20(7):1143-50. 

  26. Jabbarzadeh Kaboli P, Rahmat A, Ismail P, Ling KH. Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer. Eur J Pharmacol 2014;740:584-95. 

  27. Ortiz LM, Lombardi P, Tillhon M, Scovassi AI. Berberine, an epiphany against cancer. Molecules. 2014;19(8):12349-67. 

  28. Yu M, Tong X, Qi B, Qu H, Dong S, Yu B. Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NFkappaB. Mol Med Rep. 2014;9(1):249-54. 

  29. Kim HK, Hong SU. The anti-inflammatory effects of Huang-Lyun (Coptidis Rhizoma, CR) on injured tissue after burn elicitation. J Korean Oriental Med. 2011;32(2):1-13. 

  30. Forslin, B. A domain mosaic model of the skin barrier. Acta Derrn Venereol. 1994;74(1):1-6. 

  31. Mohsenzadeh M. Evaluation of antibacterial activity of selected Iranian essential oils against Staphylococcus aureus and Escherichia coli in nutrient broth medium. Pak J Biol Sci. 2007;10(20):3693-7. 

  32. Rasul A, Akhtar N, Khan BA, Mahmood T, Uz Zaman S, Khan HM. Formulation development of a cream containing fennel extract: in vivo evaluation for anti-aging effects. Pharmazie. 2012;67(1);54-8. 

  33. Yu HY, Yang IJ, Lincha VR, Park IS, Lee DU, Shin HM. The effects of the fruits of Foeniculum vulgare on skin barrier function and hyaluronic acid production in HaCaT Keratinocytes. J Life Sci. 2015;25(8):880-8. 

  34. Van Smeden J, Bouwstra JA. Stratum Corneum lipids: their role for the skin barrier function in healthy subjects and atopic dermatitis patients. Curr Probl Dermatol. 2016;49:8-26. 

  35. Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem. 1995;270(30):17702-11. 

  36. Kwon YB, Choi DK, Sohn KC, Jeon EK, Nam MS, Lee JH, Kim CD. Effects of colostrum on keratinocyte differentiation and wound healing. Kor J Invest Dermatol. 2007;14(2):45-50. 

  37. Smith FJ, Palmer CN, Irvine AD, Terron-Kwiatkowski A, Sandilands A, Campbell LE, Zhao Y, Liao H, Evans AT, Goudie DR, Jones SL, Arseculeratne G, Munro CS, Sergeant A, O'Regan G, Bale SJ, Compton JG, DiGiovanna JJ, Presland RB, Fleckman P, McLean WH. Loss of function mutations in the geneencoding filaggrin cause ichthyosis vulgaris. Nat Genet. 2006;38(3):337-42. 

  38. O'Regan GM, Irvine AD. The role of filaggrin in the atopic diathesis. Clin Exp Allergy. 2010;40:965-972. 

  39. Elias PM, Steinhoff M. "Outside-to-Inside" (and now back to "Outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol. 2008; 128(5):1067-70. 

  40. Kim BE, Donald YM, Boguniewicz M, Michael DH. Loricrin and involucrin expression is down-regulated by Th2 cytokines through STAT-6. Clin Immunol. 2008;126(3):332-7. 

  41. Hatano Y, Terashi H, Arakawa S, Katagiri K. Interleukin-4 suppresses the enhancement of ceramide synthesis and cutaneous permeability barrier functions induced by tumor necrosis factor-alpha and interferon-gamma in human epidermis. J Invest Dermatol. 2005;124(4):786-92. 

  42. Albanesi C, Fairchild HR, Madonna S, Scarponi C, Pita OD, Leung DY, Howell MD. IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol. 2007;179(2):984-92. 

  43. Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol. 2008;17(12):1063-72. 

  44. Baroni A, Buommino E, De Gregorio V, Ruocco E, Ruocco V, Wolf R. Structure and function of the epidermis related to barrier properties. Clin Dermatol. 2012;30(3):257-62. 

  45. Rippke F, Schreiner V, Doering T, Maibach HI. Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus. Am J Clin Dermatol. 2004;5(4):217-23. 

  46. Choi EH, Yoon NY. Pathogenesis of atopic dermatitis. J Korean Med Assoc 2014;57(3):218-25. 

  47. Kim HJ, Lee SH. The effect of skin surface on epidermal permeability barrier. J Skin Barrier Res. 2008;10(1):44-55. 

  48. Chen JQ, Liang BH, Li HP, Mo ZY, Zhu HL. Roles of kallikrein-related peptidase in epidermal barrier function and related skin diseases. Int J Dermatol Venereol. 2019;2(3):150-5. 

  49. Yamamoto M, Miyai M, Matsumoto Y, Tsuboi R, Hibino T. Kallikrein-related peptidase-7 regulates caspase-14 maturation during keratinocyte terminal differentiation by generating an intermediate form. J Biol Chem. 2012;287(39):32825-34. 

  50. Ahn SH, Kim JK, Cheon JH, Kim KB. The effect of Douchi Hataedock treatment for Dermatophagoides farinae-induced atopic dermatitis-like skin lesions by controlling IL-4 activity. J Pediatr Korean Med. 2017;31(1):43-51. 

  51. Li S, Zhang ZQ, Wu LJ, Zhang XG, Li YD, Wang YY. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Syst Biol. 2007;1(1):51-60. 

  52. Cha HY, Ahn SH, Cheon JH, Park SY, Choi JY, Kim KB. Anti-inflammatory effects of Hataedock extracted from Coptidis Rhizoma and Glycyrrhiza Uralensis on atopic dermatitis-like skin lesions of NC/Nga Mouse. J Int Korean Med. 2015;36(4):486-97. 

  53. Fu S, Ni S, Wang D, Hong T. Coptisine suppresses mast cell degranulation and ovalbumin-induced allergic rhinitis. Molecules. 2018;23(11):3039 

저자의 다른 논문 :

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로